Analyst Ratings for Lexicon Pharmaceuticals (LXRX)
LXRX Rating Summary
LXRX Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $3.10 (Citi)
- Average: $4.55
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.55 (+199.3%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$4.55 (+199.3%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/28/2026 | Cantor Fitzgerald | Steve Seedhouse | New Coverage | Overweight (N/A) |
N/A (N/A) |
1.80 (1.52) |
-15.56% | Details |
| 3/5/2025 | Leerink | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.29 (1.52) |
424.14% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
